Literature DB >> 12084014

Molecular cloning and biochemical characterization of rabbit factor XI.

Dipali Sinha1, Mariola Marcinkiewicz, David Gailani, Peter N Walsh.   

Abstract

Human factor XI, a plasma glycoprotein required for normal haemostasis, is a homodimer (160 kDa) formed by a single interchain disulphide bond linking the Cys-321 of each Apple 4 domain. Bovine, porcine and murine factor XI are also disulphide-linked homodimers. Rabbit factor XI, however, is an 80 kDa polypeptide on non-reducing SDS/PAGE, suggesting that rabbit factor XI exists and functions physiologically either as a monomer, as does prekallikrein, a structural homologue to factor XI, or as a non-covalent homodimer. We have investigated the structure and function of rabbit factor XI to gain insight into the relation between homodimeric structure and factor XI function. Characterization of the cDNA sequence of rabbit factor XI and its amino acid translation revealed that in the rabbit protein a His residue replaces the Cys-321 that forms the interchain disulphide linkage in human factor XI, explaining why rabbit factor XI is a monomer in non-reducing SDS/PAGE. On size-exclusion chromatography, however, purified plasma rabbit factor XI, like the human protein and unlike prekallikrein, eluted as a dimer, demonstrating that rabbit factor XI circulates as a non-covalent dimer. In functional assays rabbit factor XI and human factor XI behaved similarly. Both monomeric and dimeric factor XI were detected in extracts of cells expressing rabbit factor XI. We conclude that the failure of rabbit factor XI to form a covalent homodimer due to the replacement of Cys-321 with His does not impair its functional activity because it exists in plasma as a non-covalent homodimer and homodimerization is an intracellular process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084014      PMCID: PMC1222859          DOI: 10.1042/BJ20020232

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

Authors:  B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

2.  Association of factor XI and high molecular weight kininogen in human plasma.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.

Authors:  K Fujikawa; D W Chung; L E Hendrickson; E W Davie
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

4.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).

Authors:  K Fujikawa; M E Legaz; H Kato; E W Davie
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

5.  Rabbit blood coagulation factor XI. Purification and properties.

Authors:  R C Wiggins; C G Cochrane; J H Griffin
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

Review 6.  Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.

Authors:  P N Walsh
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

7.  Development of a sensitive and rapid chromogenic factor IX assay for clinical use.

Authors:  R Wagenvoord; H Hendrix; T Tran; H C Hemker
Journal:  Haemostasis       Date:  1990

8.  Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.

Authors:  H Saito; O D Ratnoff; B N Bouma; U Seligsohn
Journal:  J Lab Clin Med       Date:  1985-12

9.  Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats.

Authors:  D W Chung; K Fujikawa; B A McMullen; E W Davie
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

10.  Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds.

Authors:  M V Ragni; D Sinha; F Seaman; J H Lewis; J A Spero; P N Walsh
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

View more
  8 in total

1.  Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis.

Authors:  Paul W Riley; Hong Cheng; Dharmaraj Samuel; Heinrich Roder; Peter N Walsh
Journal:  J Mol Biol       Date:  2006-12-29       Impact factor: 5.469

2.  Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Authors:  Wenman Wu; Dipali Sinha; Sergei Shikov; Calvin K Yip; Thomas Walz; Paul C Billings; James D Lear; Peter N Walsh
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

3.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

4.  A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.

Authors:  Qiufang Cheng; Erik I Tucker; Meghann S Pine; India Sisler; Anton Matafonov; Mao-Fu Sun; Tara C White-Adams; Stephanie A Smith; Stephen R Hanson; Owen J T McCarty; Thomas Renné; András Gruber; David Gailani
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

Review 5.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

6.  Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.

Authors:  Stephen B Smith; Ingrid M Verhamme; Mao-fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

7.  The dimeric structure of factor XI and zymogen activation.

Authors:  Yipeng Geng; Ingrid M Verhamme; Stephen B Smith; Mao-Fu Sun; Anton Matafonov; Qiufang Cheng; Stephanie A Smith; James H Morrissey; David Gailani
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

Review 8.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.